Oct 13, 2020 - Podcasts

Ex-CDC director Tom Frieden on the COVID-19 vaccine race

Johnson & Johnson has paused Phase 3 trials for its COVID-19 vaccine candidate, after one patient reported an “unexplained illness.” This comes after AstraZeneca paused its Phase 3 trials due to an adverse event, and Moderna slowed its trial because of enrollment difficulties.

Axios Re:Cap goes deeper with Tom Frieden, who led the Centers for Disease Control and Prevention between 2009 and 2017.

Go deeper